1 |
Advanced Level Training Workshop in Pharmacovigilance |
Dr Sangeeta Ravat |
Advanced Level Training Workshop in Pharmacovigilance |
King Edward Memorial (KEM), Mumbai |
|
2 |
Advanced Level Training Workshop in Pharmacovigilance |
Dr Rajeev Singh Raghuvanshi Secretary cum Scientific Director, IPC |
Pharmacovigilance Program of India [PvPI]- a perspective from Indian Pharmacopoeia Commission [IPC] |
King Edward Memorial (KEM), Mumbai |
|
3 |
Advanced Level Training Workshop in Pharmacovigilance |
Dr Nilima Kshirsagar Chairperson, Core Training Panel, IPC |
Introduction to the Core Training Panel |
King Edward Memorial (KEM), Mumbai |
|
4 |
Advanced Level Training Workshop in Pharmacovigilance |
Dr Tanu Singhal Consultant in Pediatrics Kokilaben Hospital, Mumbai |
Benefit risk analysis with repurposed drugs in COVID -19 – a clinician’s perspective |
King Edward Memorial (KEM), Mumbai |
|
5 |
Advanced Level Training Workshop in Pharmacovigilance |
Dr Suparna Chatterjee Professor, IPGMER, Kolkata |
Principles and methods of vaccine signal detection |
King Edward Memorial (KEM), Mumbai |
|
6 |
Advanced Level Training Workshop in Pharmacovigilance |
Dr Sunita Chappola Shukla Director, Mumbai Allergy Center |
Drug and vaccine allergy – generating real world evidence |
King Edward Memorial (KEM), Mumbai |
|
7 |
Advanced Level Training Workshop in Pharmacovigilance |
Dr Vivek Ahuja Sun Pharma |
Shaping benefit -risk with automation and AI – a peek into the future of Pharmacovigilance |
King Edward Memorial (KEM), Mumbai |
|
8 |
Advanced Level Training Workshop in Pharmacovigilance |
Dr Viraj Rajadhyaksha Astra Zeneca, UK |
Assessing benefit -risk in the real world with the Chadox 1 COViD-19 vaccine |
King Edward Memorial (KEM), Mumbai |
|
9 |
Advanced Level Training Workshop in Pharmacovigilance |
Dr Robin Ferner Clinical Pharmacologist, City Hospital, Birmingham |
Benefit - risk assessment with Mefloquine – A UK perspective |
King Edward Memorial (KEM), Mumbai |
|